Flyer

Archives in Cancer Research

  • ISSN: 2254-6081
  • Journal h-index: 14
  • Journal CiteScore: 3.77
  • Journal Impact Factor: 4.09
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • OCLC- WorldCat
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
  • J-Gate
  • Secret Search Engine Labs
  • International Committee of Medical Journal Editors (ICMJE)
  • Zenodo
Share This Page

Case Blog - (2017) Volume 5, Issue 1

Solitary Muscular Recurrence of Nasopharyngeal Carcinoma

El-Amin Marnouche1, Halima Abahssain2 and Noureddine Benjaafar1

1Department of Radiation Oncology and Radiotherapy, National Institute of Oncology, Rabat, Morocco

2Department of Medical Oncology, National Institute of Oncology, Rabat, Morocco

*Corresponding Author:

El-Amin Marnouche
Resident of Radiation Oncology and Radiotherapy
National Institute of Oncology, Rabat, Morocco
Tel: +212665096287
E-mail: elaminmarnouche@gmail.com

Received Date: 06 January 2017; Accepted Date: 10 January 2017; Published Date: 16 January 2017

Citation: Marnouche EA, Abahssain H, Benjaafar N. Solitary Muscular Recurrence of Nasopharyngeal Carcinoma. Arch Can Res. 2017, 5:1. doi: 10.21767/2254-6081.1000124

Visit for more related articles at Archives in Cancer Research

Abstract

Angiosarcoma of breast or chest wall is a rare recognized side effect in breast cancer survivors secondary to Adjuvant radiation. The treatment of angiosarcoma of the breast is carried out in number of ways. We would like to report the case of a 50-year old woman. She developed an angiosarcoma of the breast following adjuvant radiation to her conserved breast and was successfully treated with classical Cyclophosphamide, Methotrexate, and 5- fluorouracil (CMF) chemotherapy leading to a successful local surgical salvage.

Case Presentation

\r\n\r\n

A 55-year-old Moroccan man was treated, two years ago, for nasopharyngeal carcinoma (UCNT: undifferentiated carcinoma of nasopharyngeal type) staged as T2 N2c M0 according to the seventh edition of the American Joint Committee on Cancer.

\r\n\r\n

The patient received an initial dose of 50 Gy (2 Gy per fraction) and a boost dose of 20 Gy to the primary site by three-dimensional conformal radiation therapy. After prophylactic irradiation to neck lymph nodes (level II to V), electron therapy was used to deliver a boost dose of 18 Gy (3 Gy per fraction) to the cervical lymphadenopathies. Concomitant chemotherapy based on cisplatin was administrated to the patient.

\r\n\r\n

The patient presented with 6-month history of painless swelling of the left lateral thoracic wall. Physical examination revealed a firm 5 cm mass, fixed to the deep plane. Computed tomography (CT) of chest showed a soft tissue mass, with necrosis, involving the left serratus anterior muscle (87 mm × 55 mm × 36.7 mm). This process involved partially the body of the 6th rib and the contiguous pleura with respect to lung parenchyma (Figure 1).

\"Archives-Cancer-Research-axial-thoracic\"

Figure 1: Coronal and axial thoracic CT showing a soft tissue mass involving the left serratus anterior muscle.

Biopsy of the mass was performed and the diagnosis of undifferentiated carcinoma of nasopharyngeal type was confirmed by Immunohistochemistry study [Anti-CK (cytokeratin) 7: negative/ Anti-CK 20: negative/ Anti LMP1 (latent membrane protein): negative/ Anti-P63: positive].

No other recurrences were revealed by bone scan, MRI of head and neck and hepatic ultrasonography. Therefore, patient received palliative chemotherapy with local therapy if shrinkage mass.

18133